Green Fungus Challenges in Post-COVID Health Landscape
Jeha J 1, Sudha S 1, Geetha N B 1, Benitta Sherine S 2
Journal of Angiotherapy 8(2) 1-10 https://doi.org/10.25163/angiotherapy.829463
Submitted: 12 December 2023 Revised: 12 February 2024 Published: 18 February 2024
Abstract
The emergence of Green Fungus, following instances of Black, White, and Yellow fungi, poses a new challenge in India's battle against post-COVID complications. This review represents the case of a 34-year-old COVID survivor in Madhya Pradesh diagnosed with Green Fungus (Aspergillosis), the first reported case in the state. After experiencing symptoms such as fever and nasal bleeds, the patient was diagnosed with a green fungal infection affecting his sinuses, lungs, and blood. While the origins of Green Fungus remain unclear, it is believed to stem from the ubiquitous indoor and outdoor mold fungus, Aspergillus. Unlike viruses, fungal infections like Aspergillosis are not contagious and primarily affect individuals with weakened immune systems or underlying pulmonary conditions. The symptoms of Green Fungus include fever, wheezing, reduced smelling ability, fatigue, shortness of breath, cough, and a runny nose. Prevention measures include maintaining high hygiene standards, avoiding dusty environments, and wearing N95 masks in polluted areas. The case highlights the need for heightened awareness and research into the various fungal infections affecting COVID survivors in India.
Keywords: COVID-19, Green fungus, Aspergillosis, spores.
References
Agostoni et al(2020). Cardiac patient care during a pandemic: how to reorganise a heart failure unit at the time of COVID-19. European journal of preventive cardiology, 27(11), 1127-1132.
Bassetti et al (2020). Bacterial and fungal superinfections in critically ill patients with COVID-19. Intensive care medicine, 46(11), 2071-2074.
Bermano et al (2021). Selenium and viral infection: are there lessons for COVID-19?. British journal of nutrition, 125(6), 618-627.
DeShazo et al (1997). Fungal sinusitis. New England Journal of Medicine, 337(4), 254-259.
Doi et al (2021). The merits of entomophagy in the post COVID-19 world. Trends in Food Science & Technology.
Fernandez et al (2021). Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina. Medical mycology case reports, 31, 19-23.
Fox et al (2020). Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. The Lancet Respiratory Medicine, 8(7), 681-686.
Gonzalez-Lopez et al (2020). Symptomatic Retinal Microangiophaty in a Patient with Coronavirus Disease 2019 (COVID-19): Single Case Report. Ocular immunology and inflammation, 1-3.
Herbrecht et al (2002). Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. New England Journal of Medicine, 347(6), 408-415.
Jia et al (2016). Microbial-type terpene synthase genes occur widely in nonseed land plants, but not in seed plants. Proceedings of the National Academy of Sciences, 113(43), 12328-12333.
Kazmierczak-Siedlecka et al (2020). COVID-19-gastrointestinal and gut microbiota-related aspects. European review for medical and pharmacological sciences, 24(20), 10853-10859.
Lednicky et al (2020). Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients. International Journal of Infectious Diseases, 100, 476-482.
Russell et al (2021). Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. The Lancet Microbe.
Sivankalai & Sivasekaran (2021). Mucormycosis (Block Fungus) Maiming Covid Patients: Scientometrics analysis through prism of Biblioshiny.
Wiersinga et al (2020). Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. Jama, 324(8), 782-793.
View Dimensions
View Altmetric
Save
Citation
View
Share